Purchase Order 75N92E21P00183
Award Date 6/22/21
Potential Completion Date 8/8/22
Potential Value $13K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the delivery of reagents to assist investigators working to sequence unresolved regions of the human genome. The award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has been awarded several...
- This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $12,500.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, for a license and warranty for a GridION instrument needed to support high throughput sequencing on HERVK and HIV projects. The award has an estimated completion date of April 23, 2025. There is no set-aside designation...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $101,655.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for a Nanopore Technology Sequencing Instrument. The contract has no set-aside designation and was awarded on September 26, 2019, with a completion date of October 31, 2019. Oxford Nanopore Technologies Inc. is a division of Oxford Nanopore Technologies PLC,...
- This is a $95,435 firm-fixed-price purchase order (contract) awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the supply of NANOPORE - GRIDION, a next-generation genomic sequencing platform. There is no set-aside designation associated with this award. Oxford Nanopore Technologies Inc. has...
- Oxford Nanopore Technologies Inc. was awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to deliver GridION software licenses. The solicitation sought GridION software or equal, including device warranty. As a foreign owned for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing systems and supplies consumables to support genomic research. They have provided equipment, reagents, kits and...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Oxford Nanopore Technologies Inc. for an annual software license and support renewal for the GridION platform. The potential value of this contract is $12,500.00, and it has a completion date of May 21, 2025. Oxford Nanopore Technologies Inc. is a foreign-owned, for-profit biotechnology company that develops...
- The National Heart, Lung and Blood Institute's DNA Sequencing and Genomics Core awarded a $12,500 firm fixed price purchase order to Oxford Nanopore Technologies Inc. to provide a GridION license and warranty for the sequencing device identified as GXB03004. As a foreign owned, for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing technology and delivers the GridION and PromethION sequencing platforms, MINION flow cells, and complementary reagents and kits to...
- This $12,500.00 firm fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract provides a GridION license and warranty for the NHLBI's DNA Sequencing and Genomics Core Facility, with a period of performance from March 17, 2025, to March 16, 2026. Oxford Nanopore Technologies Inc. is a prime...
- The National Human Genome Research Institute (NHGRI), a civilian agency, awarded a $23,590.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the supply of 3 packs of 4 PromethION flow cell packs (RNA) with a period of performance through December 31, 2024. This award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contract awards from agencies such as the National...